*Author Search Results*

sublabel_SolrAuthor

*Authority Data* (*EntityFactsFrom* GND / Entity Facts )

P. Gabriel Steg

Arzt

*placeOfActivity*
Paris

*Variants*
P. Steg
P. G. Steg
Gabriel Steg

More Links

Gemeinsame Normdatei (GND) im Katalog der Deutschen Nationalbibliothek

Deutsche Digitale Bibliothek

Virtual International Authority File (VIAF)

Wikidata

Effect of alirocumab on mortality after acute coronary syndromes : an analysis of the ODYSSEY OUTCOMES randomized clinical trial

Steg, P. Gabriel (Verfasser)

Circulation. - Philadelphia, Pa. : Lippincott, Williams & Wilkins, 1950-. - Online-Ressource. - ISSN 1524-4539. - Band 140, Heft 2 (2019), Seite 103-112

*eArticle*

Femoral vascular closure devices and bleeding, hemostasis, and ambulation following percutaneous coronary intervention

Marquis-Gravel, Guillaume (Verfasser)

Freiburg : Universität, 2024

*eBook*

Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction

Gibson, C. Michael (Verfasser)

Freiburg : Universität, 2020

*eBook*

Effect of alirocumab on mortality after acute coronary syndromes : : an analysis of the ODYSSEY OUTCOMES randomized clinical trial

Steg, P. Gabriel (Verfasser)

Freiburg : Universität, 2019

*eBook*

Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial

Jukema, Johan Wouter (Verfasser)

Freiburg : Universität, 2019

*eBook*

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials

Golwala, Harsh B. (Verfasser)

European heart journal. - Oxford : Oxford University Press, 1980-. - Online-Ressource. - ISSN 1522-9645. - Band 39, Heft 19 (2018), Seite 1726-1735

*eArticle*

A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: the design of the GEMINI-ACS-1 phase II study

Povsic, Thomas J. (Verfasser)

Freiburg : Universität, 2025

*eBook*

Risk categorization using New American College of Cardiology

Roe, Matthew T. (Verfasser)

Freiburg : Universität, 2020

*eBook*

The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: insights from CHAMPION PHOENIX

Yong, Celina M. (Verfasser)

Freiburg : Universität, 2020

*eBook*

*sublabel_SolrAuthor*

*Showing* 1 - 9 *of* 9

P. Gabriel Steg

*More Links*

*Narrow Search*

sublabel_SolrAuthor

Showing 1 - 9 of 9

More Links

Narrow Search